CAS RN: 199875-69-9 | Product Number: A3446

N-Arachidonoyl Dopamine

Purity: >98.0%(HPLC)

Synonyms:

NADA
(5Z,8Z,11Z,14Z)-N -[2-(3,4-Dihydroxyphenyl)ethyl]-5,8,11,14-eicosatetraenamide
(5Z,8Z,11Z,14Z)-N-(3,4-Dihydroxyphenethyl)icosa-5,8,11,14-tetraenamide

Product Documents:

Size	Unit Price	Shanghai	Tianjin	Japan*
10MG	¥1,490.00	Contact Us	Contact Us	30

* For order or inquiry, please contact Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.

Supplemental Product Information:

It is strictly forbidden to use this product for any research, production, or sale of illegal drugs.
It is strictly forbidden to export this product to the United States, Canada, Mexico, Colombia, and other countries.
Any legal issues arising from the above two clauses shall be borne by the buyer of this contract, and the supplier shall not be responsible.

General Information plus

Product Number	A3446
Purity / Analysis Method	>98.0%(HPLC)
Molecular Formula / Molecular Weight	C__2__8H__4__1NO__3 = 439.64
Physical State (20 deg.C)	Liquid
Storage Temperature	Frozen (-20°C)
Store Under Inert Gas	Store under inert gas
Condition to Avoid	Light Sensitive,Air Sensitive,Heat Sensitive
CAS RN	199875-69-9
Reaxys Registry Number	7779367
MDL Number	MFCD03412031

Specifications & Documents plus

Specifications

Appearance	Colorless to Yellow clear liquid
Purity(HPLC)(CAD)	min. 98.0 area%
NMR	confirm to structure

Properties (reference)

Flash point

341 °C

Safety & Properties plus

GHS

Related Laws:

Transport Information:

Customs Control Conditions (Q)

Applications & Literature plus

Application

N-Arachidonoyldopamine: An Endogenous Cannabinoid

N-Arachidonoyldopamine (NADA) is was first synthesized as a pharmacological tool to study the endogenous cannabinoid system (ECS).¹⁾ Later NADA and other N-acyldopamines were identified as endogenous cannabinoids in the mammalian nervous tissue.^2,3) It has been reported that NADA acts as an agonist of the cannabinoid 1 (CB₁) receptors.^1-3) It is selective for CB₁ over CB₂ receptors. Furthermore, NADA also acts as an agonist of the transient receptor potential vanilloid type 1 (TRPV1) ion channel, also known as the capsaicin receptor.^2,3) For your reference, the endogenous cannabinoid system (ECS) modulates neuronal and immune cell function, both of which play key roles in pain, therapeutics targeting this system hold promise as novel analgesics.³⁾ (The product is for research purpose only.)